Pamela E. Mason

1.1k total citations
20 papers, 945 citations indexed

About

Pamela E. Mason is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Computational Theory and Mathematics. According to data from OpenAlex, Pamela E. Mason has authored 20 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Computational Theory and Mathematics. Recurrent topics in Pamela E. Mason's work include Lipid Membrane Structure and Behavior (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Alzheimer's disease research and treatments (3 papers). Pamela E. Mason is often cited by papers focused on Lipid Membrane Structure and Behavior (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Alzheimer's disease research and treatments (3 papers). Pamela E. Mason collaborates with scholars based in United States. Pamela E. Mason's co-authors include Ronald P. Mason, Mary Walter, Mark W. Trumbore, Thomas N. Tulenko, Meng Chen, I. Tong Mak, Robert F. Jacob, Jeremiah F. Kelly, Svetlana V. Chochina and Urule Igbavboa and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes Care and Biological Psychiatry.

In The Last Decade

Pamela E. Mason

19 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela E. Mason United States 13 444 311 151 122 107 20 945
Laura Caparrotta Italy 20 738 1.7× 214 0.7× 194 1.3× 83 0.7× 168 1.6× 76 1.5k
Norio Shimamoto Japan 18 413 0.9× 399 1.3× 251 1.7× 76 0.6× 142 1.3× 56 1.3k
Hitoshi Houchi Japan 22 637 1.4× 367 1.2× 186 1.2× 112 0.9× 83 0.8× 119 1.5k
John M. Talent United States 17 625 1.4× 333 1.1× 105 0.7× 87 0.7× 39 0.4× 37 1.1k
Federico Bennardini Italy 18 580 1.3× 413 1.3× 113 0.7× 95 0.8× 63 0.6× 54 1.4k
Kazuharu Ienaga Japan 18 457 1.0× 314 1.0× 49 0.3× 98 0.8× 199 1.9× 71 1.5k
Arti Dhar India 21 654 1.5× 334 1.1× 170 1.1× 132 1.1× 40 0.4× 67 1.7k
Wolfgang Klaus Germany 20 494 1.1× 253 0.8× 493 3.3× 70 0.6× 61 0.6× 47 1.2k
Eugene E. Quist United States 15 382 0.9× 239 0.8× 63 0.4× 105 0.9× 54 0.5× 32 745
Gabriele Hakim Italy 17 503 1.1× 140 0.5× 80 0.5× 66 0.5× 91 0.9× 43 928

Countries citing papers authored by Pamela E. Mason

Since Specialization
Citations

This map shows the geographic impact of Pamela E. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela E. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela E. Mason more than expected).

Fields of papers citing papers by Pamela E. Mason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela E. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela E. Mason. The network helps show where Pamela E. Mason may publish in the future.

Co-authorship network of co-authors of Pamela E. Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela E. Mason. A scholar is included among the top collaborators of Pamela E. Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela E. Mason. Pamela E. Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ruxton, C. H. S. & Pamela E. Mason. (2011). Is black tea consumption associated with a lower risk of cardiovascular disease and type 2 diabetes?. Nutrition Bulletin. 37(1). 4–15. 10 indexed citations
3.
Mason, Pamela E., et al.. (2000). [Membrane biophysical interaction of amlodipine and antioxidant properties].. PubMed. 59 Spec No 2. 9–16. 7 indexed citations
4.
Mason, Ronald P., Mark W. Trumbore, & Pamela E. Mason. (2000). Interactions biophysiques membranaires de l???amlodipine et propri??t??s antioxydantes. Drugs. 59(Special Issue 2). 9–16. 5 indexed citations
5.
Mason, Ronald P., Peter Leeds, Robert F. Jacob, et al.. (1999). Inhibition of Excessive Neuronal Apoptosis by the Calcium Antagonist Amlodipine and Antioxidants in Cerebellar Granule Cells. Journal of Neurochemistry. 72(4). 1448–1456. 97 indexed citations
6.
Mason, Ronald P., Robert F. Jacob, Mary Walter, et al.. (1999). Distribution and Fluidizing Action of Soluble and Aggregated Amyloid β-Peptide in Rat Synaptic Plasma Membranes. Journal of Biological Chemistry. 274(26). 18801–18807. 111 indexed citations
7.
Mason, Ronald P., I. Tong Mak, Mark W. Trumbore, & Pamela E. Mason. (1999). Antioxidant properties of calcium antagonists related to membrane biophysical interactions. The American Journal of Cardiology. 84(4). 16–22. 104 indexed citations
8.
Mason, Ronald P., et al.. (1999). Membrane Antioxidant Effects of the Charged Dihydropyridine Calcium Antagonist Amlodipine. Journal of Molecular and Cellular Cardiology. 31(1). 275–281. 115 indexed citations
9.
Mason, Ronald P. & Pamela E. Mason. (1999). Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence.. Diabetes Care. 22(7). 1206–1208. 4 indexed citations
10.
Mason, Ronald P. & Pamela E. Mason. (1998). Critique of a biologic mechanism linking calcium antagonists to increased risk for cardiovascular events in diabetes. The American Journal of Cardiology. 82(9). 29–31. 5 indexed citations
11.
Lysko, Paul G., Kathryn A. Lysko, Christine L. Webb, et al.. (1998). Neuroprotective activities of carvedilol and a hydroxylated derivative. Biochemical Pharmacology. 56(12). 1645–1656. 27 indexed citations
12.
Mason, Ronald P., I. Tong Mak, Mary Walter, Thomas N. Tulenko, & Pamela E. Mason. (1998). Antioxidant and Cytoprotective Activities of the Calcium Channel Blocker Mibefradil. Biochemical Pharmacology. 55(11). 1843–1852. 29 indexed citations
13.
Tulenko, Thomas N., Meng Chen, Pamela E. Mason, & Ronald P. Mason. (1998). Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis. Journal of Lipid Research. 39(5). 947–956. 146 indexed citations
14.
Mason, Pamela E., et al.. (1998). Biophysical membrane interactions of steroid hormones: a potential complementary mechanism of steroid action.. PubMed. 21(3). 181–9. 20 indexed citations
15.
Mason, Ronald P., Mary Walter, & Pamela E. Mason. (1997). Effect of Oxidative Stress on Membrane Structure: Small-Angle X-Ray Diffraction Analysis. Free Radical Biology and Medicine. 23(3). 419–425. 100 indexed citations
16.
Walter, Mary, Pamela E. Mason, & Ronald P. Mason. (1997). Alzheimer's Disease Amyloid β Peptide 25-35 Inhibits Lipid Peroxidation as a Result of Its Membrane Interactions. Biochemical and Biophysical Research Communications. 233(3). 760–764. 36 indexed citations
17.
Mason, Ronald P., et al.. (1996). Alzheimer's Disease Amyloid β Peptide 25-35 Is Localized in the Membrane Hydrocarbon Core: X-Ray Diffraction Analysis. Biochemical and Biophysical Research Communications. 222(1). 78–82. 91 indexed citations
18.
Mason, Ronald P., et al.. (1996). Steroid effects on cell membrane structure: Implications for depressive illness. Biological Psychiatry. 39(7). 585–585. 1 indexed citations
19.
Herbette, Leo G., Pamela E. Mason, Kevin Sweeney, Mark W. Trumbore, & Ronald P. Mason. (1994). Favorable amphiphilicity of nimodipine facilitates Its interactions with brain membranes. Neuropharmacology. 33(2). 241–249. 20 indexed citations
20.
Herbette, Leo G., et al.. (1994). The Molecular Basis for Lacidipineʼs Unique Pharmacokinetics. Journal of Cardiovascular Pharmacology. 23. S16–S25. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Caparrotta Breakdown of academic impact, for papers by Norio Shimamoto Breakdown of academic impact, for papers by Hitoshi Houchi Breakdown of academic impact, for papers by John M. Talent Breakdown of academic impact, for papers by Federico Bennardini Breakdown of academic impact, for papers by Kazuharu Ienaga Breakdown of academic impact, for papers by Arti Dhar Breakdown of academic impact, for papers by Wolfgang Klaus Breakdown of academic impact, for papers by Eugene E. Quist Breakdown of academic impact, for papers by Gabriele Hakim
Rankless by CCL
2026